Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878

NCT06607484 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Healthy Volunteers

Interventions

DRUG: SR-878
DRUG: Placebo

Sponsor

SciRhom GmbH